Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA4 | P22748 | 3/20 | 0.35 |
| ▸ | CA9 | Q16790 | 3/20 | 0.35 |
| ▸ | CA7 | P43166 | 2/20 | 0.35 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.35 |
| ▸ | CA6 | P23280 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.33 |
| ▸ | TSHR | P16473 | 4/20 | 0.32 |
| ▸ | CA1 | P00915 | 2/20 | 0.30 |
| ▸ | CA2 | P00918 | 2/20 | 0.30 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.30 |
| ▸ | CA12 | O43570 | 1/20 | 0.30 |
| ▸ | GLA | P06280 | 1/20 | 0.30 |
| ▸ | CA3 | P07451 | 1/20 | 0.30 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.30 |
| ▸ | ACHE | P22303 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL37140 | 0.97 | — | — | |
| Water SCHEMBL11963057 | 0.93 | — | — | |
| Fluoride Ion SCHEMBL6315266 | 0.93 | — | — | |
| Hydrochloric Acid SCHEMBL3796670 | 0.93 | CA4 (0.35) | CA4CA9CA7CA14CA6 | |
| Bromide SCHEMBL11327569 | 0.93 | CA4 (0.35) | CA4CA9CA7CA14CA6 | |
| Ammonia Solution, Strong SCHEMBL23611461 | 0.93 | — | — | |
| Hydrochloric Acid SCHEMBL8384341 | 0.93 | — | — | |
| SCHEMBL7541997 | 0.93 | — | — | |
| SCHEMBL11571044 | 0.93 | — | — | |
| Iodide SCHEMBL18428509 | 0.93 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170158637-A1 | Synthetic Processes of Carprofen | CHEMWERTH, INC. | 2017-06-08 | — | — | US | disclosed |
| US-9611217-B2 | Synthetic processes of carprofen | CHEMWERTH, INC. (US) | 2017-04-04 | — | — | US | disclosed |
| US-20160326113-A1 | Synthetic Processes of Carprofen | CHEMWERTH, INC. | 2016-11-10 | — | — | US | disclosed |
| EP-3091000-A1 | SYNTHETIC PROCESS OF CARPROFEN | ChemWerth, Inc. (US) | 2016-11-09 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160326113-A1 | Synthetic Processes of Carprofen | CYP4F2, CYP4F3, CYP2J2 | CA4 2587/4885CA9 4106/4885CA7 2959/4885 |
| US-20170158637-A1 | Synthetic Processes of Carprofen | CYP4F2, CYP4F3, CYP2J2 | CA4 2587/4885CA9 4106/4885CA7 2959/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.